More than 25 years of clinical trial data have established statins as first-line therapy for the prevention and treatment of atherosclerotic cardiovascular disease. With regard to low-density ...
A new study in the Lancet attempted to calm fears about the side-effects of statins in people at low risk of heart disease – but seems to have reignited a bitter row in the medical ...
Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...